##gff-version 3
##sequence-region Q9NQ11 1 1180
Q9NQ11	UniProtKB	Chain	1	1180	.	.	.	ID=PRO_0000046423;Note=Cation-transporting ATPase 13A2	
Q9NQ11	UniProtKB	Topological domain	1	12	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	13	34	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	35	45	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	46	66	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	67	230	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	231	253	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	254	256	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	257	276	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	277	425	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	426	445	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	446	459	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	460	480	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	481	932	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	933	952	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	953	963	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	964	981	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	982	997	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	998	1018	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	1019	1046	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	1047	1066	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	1067	1079	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	1080	1097	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	1098	1113	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Transmembrane	1114	1134	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Topological domain	1135	1180	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9NQ11	UniProtKB	Active site	513	513	.	.	.	Note=4-aspartylphosphate intermediate;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NQ11	UniProtKB	Metal binding	878	878	.	.	.	Note=Magnesium;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NQ11	UniProtKB	Metal binding	882	882	.	.	.	Note=Magnesium;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9NQ11	UniProtKB	Modified residue	151	151	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9NQ11	UniProtKB	Alternative sequence	155	159	.	.	.	ID=VSP_007310;Note=In isoform B and isoform 3. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334,ECO:0000303|Ref.2,ECO:0000303|Ref.8;Dbxref=PMID:14702039,PMID:15489334	
Q9NQ11	UniProtKB	Alternative sequence	805	843	.	.	.	ID=VSP_007311;Note=In isoform B. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|Ref.8;Dbxref=PMID:15489334	
Q9NQ11	UniProtKB	Alternative sequence	1079	1180	.	.	.	ID=VSP_007312;Note=In isoform B. VPFLVALALLSSVLVGLVLVPGLLQGPLALRNITDTGFKLLLLGLVTLNFVGAFMLESVLDQCLPACLRRLRPKRASKKRFKQLERELAEQPWPPLPAGPLR->ERARPVPPRLPAPPPAQAGLQEALQAAGTRAGRAALAAAARRPPEVVQAHGHPRHWNSLPLSHQLDPSPATPPPPPPTSLRLATVYTPPPRPPPPWGSVDYCPLPWTIPRRGGSPQLPSVLLSV;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|Ref.8;Dbxref=PMID:15489334	
Q9NQ11	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_058451;Note=In KRS%3B no effect on stability%3B no effect on location%3B decreased ATPase activity. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17485642,ECO:0000269|PubMed:22768177;Dbxref=dbSNP:rs151117874,PMID:17485642,PMID:22768177	
Q9NQ11	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_058452;Note=G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19085912;Dbxref=dbSNP:rs56379718,PMID:19085912	
Q9NQ11	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_066019;Note=In KRS%3B decreased protein stability%3B loss of autophosphorylation%3B increased degradation by proteasome%3B novel location to endoplasmic reticulum%3B loss of lysosomal membrane location. F->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18413573,ECO:0000269|PubMed:22768177,ECO:0000269|PubMed:28137957;Dbxref=PMID:18413573,PMID:22768177,PMID:28137957	
Q9NQ11	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_058453;Note=R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19085912;Dbxref=dbSNP:rs56367069,PMID:19085912	
Q9NQ11	UniProtKB	Natural variant	389	389	.	.	.	ID=VAR_058454;Note=P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19085912;Dbxref=dbSNP:rs56275621,PMID:19085912	
Q9NQ11	UniProtKB	Natural variant	504	504	.	.	.	ID=VAR_058455;Note=In KRS%3B decreased protein stability%3B increased degradation by proteasome%3B novel location to endoplasmic reticulum%3B loss of lysosomal membrane location. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17485642,ECO:0000269|PubMed:22768177;Dbxref=dbSNP:rs121918227,PMID:17485642,PMID:22768177	
Q9NQ11	UniProtKB	Natural variant	517	517	.	.	.	ID=VAR_078055;Note=In SPG78%3B no effect on protein stability%3B loss of autophosphorylation%3B loss of lysosomal location. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28137957;Dbxref=dbSNP:rs1057519291,PMID:28137957	
Q9NQ11	UniProtKB	Natural variant	522	522	.	.	.	ID=VAR_078056;Note=In KRS%3B unknown pathological significance. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22296644;Dbxref=PMID:22296644	
Q9NQ11	UniProtKB	Natural variant	533	533	.	.	.	ID=VAR_058456;Note=In a patient with early onset Parkinson disease and KRS%3B decreased ATPase activity%3B no effect on autophosphorylation%3B no effect on stability%3B no effect on location. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17485642,ECO:0000269|PubMed:22768177,ECO:0000269|PubMed:28137957;Dbxref=PMID:17485642,PMID:22768177,PMID:28137957	
Q9NQ11	UniProtKB	Natural variant	578	578	.	.	.	ID=VAR_058457;Note=V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19085912;Dbxref=dbSNP:rs56186751,PMID:19085912	
Q9NQ11	UniProtKB	Natural variant	746	746	.	.	.	ID=VAR_058458;Note=In KRS%3B decreased ATPase activity%3B no effect on stability%3B no effect on location. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19015489,ECO:0000269|PubMed:22768177;Dbxref=dbSNP:rs147277743,PMID:19015489,PMID:22768177	
Q9NQ11	UniProtKB	Natural variant	762	762	.	.	.	ID=VAR_058459;Note=R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19085912;Dbxref=dbSNP:rs55635527,PMID:19085912	
Q9NQ11	UniProtKB	Natural variant	776	776	.	.	.	ID=VAR_058460;Note=V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19085912;Dbxref=dbSNP:rs56170027,PMID:19085912	
Q9NQ11	UniProtKB	Natural variant	854	854	.	.	.	ID=VAR_070194;Note=In KRS%3B some patients manifest neuropathologic findings suggestive of neuronal ceroid lipofuscinosis. M->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22388936;Dbxref=dbSNP:rs587777053,PMID:22388936	
Q9NQ11	UniProtKB	Natural variant	877	877	.	.	.	ID=VAR_066020;Note=In KRS%3B found in two affected brothers also carrying C-481 in FBXO7%3B decreased protein stability%3B increased degradation by proteasome%3B novel location to endoplasmic reticulum. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20853184,ECO:0000269|PubMed:22768177;Dbxref=dbSNP:rs144701072,PMID:20853184,PMID:22768177	
Q9NQ11	UniProtKB	Natural variant	946	946	.	.	.	ID=VAR_058461;Note=I->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19085912;Dbxref=dbSNP:rs55708915,PMID:19085912	
Q9NQ11	UniProtKB	Natural variant	1059	1059	.	.	.	ID=VAR_066021;Note=In KRS%3B the mutant protein is retained in the endoplasmic reticulum. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21542062;Dbxref=dbSNP:rs137853967,PMID:21542062	
Q9NQ11	UniProtKB	Mutagenesis	513	513	.	.	.	Note=Loss of ATPase function. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28137957;Dbxref=PMID:28137957	
Q9NQ11	UniProtKB	Sequence conflict	322	322	.	.	.	Note=Q->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9NQ11	UniProtKB	Sequence conflict	855	858	.	.	.	Note=APEQ->IPRA;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9NQ11	UniProtKB	Sequence conflict	861	861	.	.	.	Note=E->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
